Thomas E. Renau
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Cancer therapeutics and mechanisms 5
- Phenothiazines and Benzothiazines Synthesis and Activities 4
-
- Synthesis and Biological Evaluation 10
- Quinazolinone synthesis and applications 4
- Co-authors
- Roger Léger (6 shared papers)Ving J. Lee (6 shared papers)Suzanne Chamberland (5 shared papers)Toshiharu Ohta (5 shared papers)Kiyoshi Nakayama (5 shared papers)Eric M. Flamme (4 shared papers)Olga Lomovskaya (5 shared papers)Rose Yen (4 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (8 papers)Journal of Medicinal Chemistry (6 papers)Antimicrobial Agents and Chemotherapy (4 papers)Antiviral Research (2 papers)Blood (2 papers)
- Partner nations
- United StatesJapan
In The Last Decade
Thomas E. Renau
29 papers receiving 856 citations
Peers
Comparison fields: 5 of 72
- Molecular Medicine 502
- Pharmacology 270
- Infectious Diseases 183
- Microbiology 58
- Applied Microbiology and Biotechnology 17
Countries citing papers authored by Thomas E. Renau
This map shows the geographic impact of Thomas E. Renau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Renau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Renau more than expected).
Fields of papers citing papers by Thomas E. Renau
This network shows the impact of papers produced by Thomas E. Renau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Renau. The network helps show where Thomas E. Renau may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas E. Renau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 219 | |
| 2 | 2003 | 76 | |
| 3 | 2003 | 66 | |
| 4 | 1996 | 66 | |
| 5 | 2003 | 64 | |
| 6 | 2002 | 60 | |
| 7 | 2001 | 50 | |
| 8 | 2003 | 48 | |
| 9 | 1996 | 42 | |
| 10 | 1995 | 34 | |
| 11 | 1996 | 30 | |
| 12 | The potential of phosphodiesterase 4 inhibitors for the treatment of depression: opportunities and challenges. | 2004 | 25 |
| 13 | 1996 | 24 | |
| 14 | 1999 | 22 | |
| 15 | 1996 | 17 | |
| 16 | 2004 | 13 | |
| 17 | 2001 | 13 | |
| 18 | 1995 | 12 | |
| 19 | 1992 | 11 | |
| 20 | 1992 | 11 |
About Thomas E. Renau
Thomas E. Renau is a scholar working on Molecular Biology, Organic Chemistry, Epidemiology, Molecular Medicine and Infectious Diseases, having authored 29 papers that have together received 942 indexed citations. Recurring topics across this work include Synthesis and Biological Evaluation (10 papers), Antibiotic Resistance in Bacteria (8 papers), Cancer therapeutics and mechanisms (5 papers), Quinazolinone synthesis and applications (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Phenothiazines and Benzothiazines Synthesis and Activities (4 papers), Cytomegalovirus and herpesvirus research (4 papers) and HIV/AIDS drug development and treatment (4 papers). The work is most often cited by research in Molecular Medicine (502 citations), Pharmacology (270 citations), Infectious Diseases (183 citations), Microbiology (58 citations) and Applied Microbiology and Biotechnology (17 citations). Thomas E. Renau has collaborated with scholars based in United States and Japan. Frequent co-authors include Roger Léger, Ving J. Lee, Suzanne Chamberland, Toshiharu Ohta, Kiyoshi Nakayama, Eric M. Flamme, Olga Lomovskaya, Rose Yen, John C. Drach and Joan Sangalang. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy, Antiviral Research and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.